P-187: Expert elicitation of long-term survival (LTS) for patients (pts) with relapsed/refractory multiple myeloma (RRMM) treated with idecabtagene vicleucel (ide-cel, bb2121) in the KarMMa phase 2 trial
Title:
P-187: Expert elicitation of long-term survival (LTS) for patients (pts) with relapsed/refractory multiple myeloma (RRMM) treated with idecabtagene vicleucel (ide-cel, bb2121) in the KarMMa phase 2 trial
Author:
Ayers, Dieter Cope, Shannon Dhanda, Devender S. Towle, Kevin Mojebi, Ali Delforge, Michel RodrÃguez-Otero, Paula Trudel, Suzanne Weisel, Katja Zamagni, Elena Hari, Parameswaran